Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1992 1
1993 1
1994 2
1995 3
1996 12
1997 8
1998 10
1999 17
2000 12
2001 18
2002 12
2003 8
2004 5
2005 5
2006 4
2007 10
2008 13
2009 4
2010 2
2011 3
2012 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Development of resistance against diketo derivatives of human immunodeficiency virus type 1 by progressive accumulation of integrase mutations.
Fikkert V, Van Maele B, Vercammen J, Hantson A, Van Remoortel B, Michiels M, Gurnari C, Pannecouque C, De Maeyer M, Engelborghs Y, De Clercq E, Debyser Z, Witvrouw M. Fikkert V, et al. Among authors: witvrouw m. J Virol. 2003 Nov;77(21):11459-70. doi: 10.1128/jvi.77.21.11459-11470.2003. J Virol. 2003. PMID: 14557631 Free PMC article.
In search of authentic inhibitors of HIV-1 integration.
Debyser Z, Cherepanov P, Van Maele B, De Clercq E, Witvrouw M. Debyser Z, et al. Among authors: witvrouw m. Antivir Chem Chemother. 2002 Jan;13(1):1-15. doi: 10.1177/095632020201300101. Antivir Chem Chemother. 2002. PMID: 12180645 Free article. Review.
Mutations in both env and gag genes are required for HIV-1 resistance to the polysulfonic dendrimer SPL2923, as corroborated by chimeric virus technology.
Hantson A, Fikkert V, Van Remoortel B, Pannecouque C, Cherepanov P, Matthews B, Holan G, De Clercq E, Vandamme AM, Debyser Z, Witvrouw M. Hantson A, et al. Among authors: witvrouw m. Antivir Chem Chemother. 2005;16(4):253-66. doi: 10.1177/095632020501600405. Antivir Chem Chemother. 2005. PMID: 16130523 Free article.
Novel inhibitors of HIV-1 integration.
Witvrouw M, Van Maele B, Vercammen J, Hantson A, Engelborghs Y, De Clercq E, Pannecouque C, Debyser Z. Witvrouw M, et al. Curr Drug Metab. 2004 Aug;5(4):291-304. doi: 10.2174/1389200043335487. Curr Drug Metab. 2004. PMID: 15320701 Review.
Evaluation of the anti-HIV activity of statins.
Moncunill G, Negredo E, Bosch L, Vilarrasa J, Witvrouw M, Llano A, Clotet B, Esté JA. Moncunill G, et al. Among authors: witvrouw m. AIDS. 2005 Oct 14;19(15):1697-700. doi: 10.1097/01.aids.0000183517.60384.db. AIDS. 2005. PMID: 16184043 Clinical Trial.
Anti-HIV-1 activity of benzothiadiazine dioxide.
Martinez A, Gil C, Castro A, Perez C, Witvrouw M, Pannecouque C, Balzarini J, De Clercq E. Martinez A, et al. Among authors: witvrouw m. Antivir Chem Chemother. 2001 Nov;12(6):347-51. doi: 10.1177/095632020101200604. Antivir Chem Chemother. 2001. PMID: 12018679 Free article.
151 results